Flagship Founder and CEO Noubar Afeyan was joined by Aviv Regev, Executive Vice President at Genentech Research and Early Development (gRED) for a fascinating discussion on the intersection of AI and biology, the future of R&D, and the leaps in store for biomedicine. More from Flagship @ JPM2023 here.
More from:
Human Health
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Three Questions with Volker Herrmann, Flagship CEO-Partner & CEO of Sonata Therapeutics
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support